Pharmalot... Pharmalittle... Good Morning
Hello, everyone, and how are you today? Gray skies are hovering over the Pharmalot corporate campus this morning as we await what prognosticators say will be a blustery storm. Nonetheless, our spirits remain sunny. Why? We will repeat the mantra taught us years ago by the Morning Mayor: 'Every brand day should be unwrapped like a precious gift.' Sometimes, living life with a little urgency is a good thing. Anyway, enough philosophy. There is work to do. Time to hoist the cup of stimulation and attack the to-do list. Here are some tidbits. Hope you have a grand day...
Bayer In Talks To Buy Algeta For $2.4 Billion (Bloomberg News)
ADHD Prevalence Is Still Rising: CDC (MedPage Today)
Mylan Gets OK For Herceptin Biosimilar In India (Pharma Times)
Parent Attitudes Toward Sex & Cost Stymie HPV Vaccines (Bloomberg News)
Sanofi To Spend Up To $2.7B A Year On Acquisitions (Reuters)
Med Errors Common On Admission To Mental Health Units (Science Daily)
FDA OKs Expanded Use For Bayer Thyroid Cancer Drug (PM Live)
EDITOR'S NOTE: Please check this post for additional stories during the day
Read more
Source: Pharmalot - Category: Pharma Commentators Authors: esilverman Source Type: blogs
More News: ADHD | Cancer | Cancer & Oncology | Cancer Vaccines | Health | Herceptin | Men | Mergers and Aquisitions | Pharma Commentators | Pharmaceuticals | Science | Thyroid | Thyroid Cancer | Vaccines